Table 4.
Previously Reported Cases of EBV negative Marginal Zone Lymphoma in Transplant Patients
| Age/Sex | Type of Transplant | Time from Transplant (months) | Anatomic Site | H.pylori | EBV status | Treatment | Follow-up | Reference |
|---|---|---|---|---|---|---|---|---|
| 53/F | Kidney | 60 | Gastric | Pos | NI | Antibiotics | Alive, no active disease at 24 months | Le Meur Y et al. |
| 46/F | Kidney & pancreas | 110 | Gastric | Pos | Neg | Antibiotics, RI | Alive, no active disease at 12 months | Aull MJ et al. |
| 58/M | Heart | 42 | Gastric | Pos | NI | Antibiotics, RI | Alive, no active disease at 12 months | Aull MJ et al. |
| 52/M | Kidney | 51 | Gastric | Pos | NI | Antibiotics, RI, RT | Alive, no active disease at 34 months | Aull MJ et al. |
| 51/F | Kidney | 67 | Gastric | Neg | NI | Antibiotics, RI | Alive, no active disease at 7 months | Aull MJ et al. |
| 51/M | Heart | 52 | Gastric | Pos | NI | Antibiotics, RI, Surgery & Chemotherapy | Dead at 15 months (Infection) | Aull MJ et al. |
| 61/F | Kidney | 51 | Gastric | Pos | NI | Antibiotics, RI | Alive, no active disease at 38 months | Aull MJ et al. |
| 57/M | Liver | 104 | Gastric | Pos | Neg | Antibiotics | Alive, no active disease at 48 months | Shehab TM et al. |
| 61/F | Liver | 94 | Gastric | Pos | Neg | Antibiotics | Alive, no active disease at 8 months | Shehab TM et al. |
| 54/F | Liver | 33 | Gastric | Pos | Neg | Antibiotics | Alive, no active disease at 10 months | Shehab TM et al. |
| 48/M | Liver | 60 | Gastric | Pos | Neg | Antibiotics, RT | Died at 36 months secondary to metastatic gastric adenocarcinoma | Hsi ED et al. and Shehab TM et al. |
| 47/F | Kidney | 132 | Parotid | NA | Neg | RT | Alive, no active disease at 14 months | Hsi ED et al. |
| 63/F | Liver | 131 | Parotid | NA | Neg | RI | Alive, no active disease at 24 months | Hsi ED et al. |
| 50/M | Heart | 14 | Gastric | Pos | Neg | Antibiotics, RT, Surgery | Alive, no active disease at 12 months | Hsi ED et al. |
| 48/M | Heart | 84 | Gastric | Pos | Neg | RI, Surgery | Alive, no active disease at 11 months | Hsi ED et al. |
| 52/M | Liver | 52 | Colon | NA | Neg | RI, Surgery | Alive | Kim MJ et al. |
| 43/M | Liver | 27.5 | Liver, spleen, BM, LN | NA | Neg | Rituximab-Chemotherapy | Alive | Oertel SH et al. |
| 58/F | Liver | 24 | R Lower Lobe, Lung | NA | Neg | Surgery | Alive, no active disease at 12 months | Shoji F et al. |
| 60/M | Heart | 72 | Gastric | Pos | Neg | Antibiotics, Chemotherapy | Alive, no active disease at 48 months | Boissonnat P et al. |
| 28/F | Kidney | 72 | Gastric | Pos | Neg | Antibiotics, RI, Chemotherapy | Alive, no active disease at 60 months | Bakanay SM et al. |
| 52/M | Heart | 60 | Gastric | Pos | Neg | Chemotherapy | Alive, no active disease at 24 months | Wotherspoon AC et al. |
| 70/M | Kidney | 60 | Gastric with involvement of oral cavity, lung, LN | Pos | Neg | Chemotherapy | Alive, no active disease at 10 months | Wotherspoon AC et al. |
| 50/M | Kidney | 136 | Gastric | NI | NI | Rituximab-Chemotherapy | Alive, no active disease | Ashrafi F et al. |
| 60/F | HSCT | 132 | Cecum | NA | Neg | RT | Alive, no active disease at 6 months | Sundararajan S et al. |
BM, Bone marrow; LN, Lymph node; NA, Not applicable; Neg, Negative; NI, No information available; Pos, Positive; R, Right; RI, reduced immunosuppression; RT, Radiotherapy